Louis C. Mahadevan
- Molecular Biology top 1%
- Genomics and Chromatin Dynamics 15
- Melanoma and MAPK Pathways 12
- Protein Kinase Regulation and GTPase Signaling 12
- Ubiquitin and proteasome pathways 8
- Epigenetics and DNA Methylation 6
- RNA Research and Splicing 6
- Histone Deacetylase Inhibitors Research 5
- Protein Degradation and Inhibitors 5
- Cancer Research top 2%
- Aging top 5%
- Immunology top 5%
- Cell Biology top 2%
- Co-authors
- Catherine A. HazzalinEva CanoAlison L. ClaytonMichael J. BarrattJohn W. EdmundsStuart ThomsonDylan R. EdwardsAnthony C. Willis
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Louis C. Mahadevan
52 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 5.1k
- Cancer Research 688
- Aging 64
- Immunology 730
- Cell Biology 532
Countries citing papers authored by Louis C. Mahadevan
This map shows the geographic impact of Louis C. Mahadevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Louis C. Mahadevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Louis C. Mahadevan more than expected).
Fields of papers citing papers by Louis C. Mahadevan
This network shows the impact of papers produced by Louis C. Mahadevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Louis C. Mahadevan. The network helps show where Louis C. Mahadevan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Louis C. Mahadevan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 4 | |
| 2 | 2012 | 17 | |
| 3 | 2012 | 41 | |
| 4 | Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitorbreakdown → | 2010 | 504 |
| 5 | 2009 | 29 | |
| 6 | 2007 | 410 | |
| 7 | 2006 | 365 | |
| 8 | 2005 | 96 | |
| 9 | 2005 | 177 | |
| 10 | 2004 | 11 | |
| 11 | 2003 | 154 | |
| 12 | 2001 | 176 | |
| 13 | 1998 | 162 | |
| 14 | 1997 | 87 | |
| 15 | Identification of anisomycin-activated kinases p45 and p55 in murine cells as MAPKAP kinase-2. | 1996 | 78 |
| 16 | 1996 | 193 | |
| 17 | Parallel signal processing among mammalian MAPKsbreakdown → | 1995 | 907 |
| 18 | 1994 | 40 | |
| 19 | 1992 | 18 | |
| 20 | 1988 | 2 |
About Louis C. Mahadevan
Louis C. Mahadevan is a scholar working on Molecular Biology, Toxicology and Aging, having authored 52 papers that have together received 6.4k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (15 papers), Melanoma and MAPK Pathways (12 papers), Protein Kinase Regulation and GTPase Signaling (12 papers), Ubiquitin and proteasome pathways (8 papers), Epigenetics and DNA Methylation (6 papers), RNA Research and Splicing (6 papers), Histone Deacetylase Inhibitors Research (5 papers) and Protein Degradation and Inhibitors (5 papers). The work is most often cited by research in Molecular Biology (5.1k citations), Cancer Research (688 citations) and Aging (64 citations). Louis C. Mahadevan has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Catherine A. Hazzalin, Eva Cano, Alison L. Clayton, Michael J. Barratt, John W. Edmunds, Stuart Thomson, Dylan R. Edwards, Anthony C. Willis, Karine Rutault and Ana Cuenda. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.